Ekene Enemchukwu, MD, MPH, FACS, URPS

home / authors / ekene-enemchukwu-md-mph-facs-urps

Enemchukwu is an associate professor of urology, and by courtesy, of obstetrics and gynecology (urogynecology), at Stanford Medicine in Palo Alto, California.

Articles

Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use

Ekene Enemchukwu, MD, MPH, FACS, URPS;Hannah Clarke

April 22nd 2025

Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen

Ekene Enemchukwu, MD, MPH, FACS, URPS;Hannah Clarke

April 18th 2025

There is also a need to improve multidisciplinary care, according to Ekene Enemchukwu, MD.

Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM

Ekene Enemchukwu, MD, MPH, FACS, URPS;Hannah Clarke

April 15th 2025

“Given the rates in epidemiologic studies and surveys showing that up to 70% of women are symptomatic, we were surprised to find that only 9% [filled] a prescription,” says Ekene Enemchukwu, MD, MPH, FACS, URPS.

Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM

Ekene Enemchukwu, MD, MPH, FACS, URPS;Hannah Clarke

April 11th 2025

"What we found is that 9% of women with a GSM-related diagnosis filled a prescription for vaginal estrogen during the study period, and these women tended to be younger," says Ekene Enemchukwu, MD, MPH, FACS, URPS.

Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause

Ekene Enemchukwu, MD, MPH, FACS, URPS;Hannah Clarke

April 7th 2025

“To find a therapy that's all encompassing, that manages all of this in a long-term fashion, low-dose vaginal estrogen is the preferred treatment,” says Ekene Enemchukwu, MD, MPH, FACS, URPS.